- Home
- ILMN vs DOCS Comparison
ILMN vs DOCS Comparison
Compare ILMN & DOCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- DOCS
- Stock Information
- Founded
- ILMN 1998
- DOCS 2010
- Country
- ILMN United States
- DOCS United States
- Employees
- ILMN N/A
- DOCS N/A
- Industry
- ILMN Medical Specialities
- DOCS Retail: Computer Software & Peripheral Equipment
- Sector
- ILMN Health Care
- DOCS Technology
- Exchange
- ILMN Nasdaq
- DOCS Nasdaq
- Market Cap
- ILMN 15.3B
- DOCS 13.7B
- IPO Year
- ILMN 2000
- DOCS 2021
- Fundamental
- Price
- ILMN $96.70
- DOCS $72.44
- Analyst Decision
- ILMN Buy
- DOCS Buy
- Analyst Count
- ILMN 15
- DOCS 19
- Target Price
- ILMN $124.27
- DOCS $69.79
- AVG Volume (30 Days)
- ILMN 1.7M
- DOCS 1.4M
- Earning Date
- ILMN 11-03-2025
- DOCS 11-06-2025
- Dividend Yield
- ILMN N/A
- DOCS N/A
- EPS Growth
- ILMN N/A
- DOCS 45.79
- EPS
- ILMN 7.91
- DOCS 1.17
- Revenue
- ILMN $4,284,000,000.00
- DOCS $589,636,000.00
- Revenue This Year
- ILMN N/A
- DOCS $13.30
- Revenue Next Year
- ILMN $2.74
- DOCS $10.94
- P/E Ratio
- ILMN $12.21
- DOCS $62.07
- Revenue Growth
- ILMN N/A
- DOCS 19.45
- 52 Week Low
- ILMN $68.70
- DOCS $40.87
- 52 Week High
- ILMN $156.66
- DOCS $85.21
- Technical
- Relative Strength Index (RSI)
- ILMN 47.19
- DOCS 53.27
- Support Level
- ILMN $95.77
- DOCS $70.16
- Resistance Level
- ILMN $103.00
- DOCS $73.92
- Average True Range (ATR)
- ILMN 3.53
- DOCS 2.29
- MACD
- ILMN 0.02
- DOCS -0.44
- Stochastic Oscillator
- ILMN 48.30
- DOCS 43.20
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.